Ask your doctor if the 900 mg tablet1 is right for you

Discover a once-daily
treatment for relief from
postherpetic neuralgia (PHN)1

450 mg, and 750 mg strengths also available.
Not actual patients.


  1. GRALISE. Prescribing information. Almatica Pharma LLC; 2023.
  2. Sang CN, Sathyanarayana R, Sweeney M; DM-1796 Study Investigators. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Clin J Pain. 2013;29(4):281-288.
  3. Mehta N, Bucior I, Bujanover S, Shah R, Gulati A. Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin. Health Qual Life Outcomes. 2016;14:54.
  4. Argoff CE, Chen C, Cowles VE. Clinical development of a once-daily gastroretentive formulation of gabapentin for treatment of postherpetic neuralgia: an overview. Expert Opin Drug Deliv. 2012;9(9):1147-1160.
  5. Chen C, Cowles VE, Hou E. Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food. J Clin Pharmacol. 2011;51(3):346-358.
Savings card

Most patients pay as little as $20*

Download savings card
*Applies to commercially insured patients. Individual costs may vary. Program eligibility and restrictions apply.